While its official symbol is FGL1 for fibrinogen‐like 1, it is also commonly referred to as hepassocin (HPS) or HFREP1 in studies that have yielded sometimes opposite conclusions depending on the strategy used to assess the potential function of FGL1 in metabolic diseases. The gene discussed is FGL1; the disease is Other metabolic disease.